RxDoctor Payments DataLook up a doctor →

Cass Nakasone, MD

Orthopaedic Surgery · Honolulu, HINPI 1316011091

Payments from drug & device makers

$1,009,388in general payments, 2019–2025

Across 391 payments — averaging $2581.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ortho Development Corporation$888K
  • Zimmer Biomet$67K
  • Encore Medical, LP$32K
  • Orthalign Inc$20K
  • Think Surgical, Inc.$1K
  • Smith+Nephew$333
  • plus $1K from 10 others
$1,779in research payments, 2019–2025

Across 2 payments — averaging $889.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,009,388 in reported general payments places this provider in the 95th percentile of 83 orthopaedic surgery providers in Hawaii.

See all orthopaedic surgery providers in Hawaii

Medicare billing

Part B allowed, 2024
$283,074
Medicare patients
311
Services billed
510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →